PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Provectus Biopharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Provectus Biopharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 12.2 %, a 35.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 12.2 -6.81 -35.7% Sep 30, 2024
Q2 2024 13.6 -6.55 -32.5% Jun 30, 2024
Q1 2024 15.6 -6.91 -30.8% Mar 31, 2024
Q4 2023 17.1 -9.24 -35% Dec 31, 2023
Q3 2023 19.1 -12.4 -39.4% Sep 30, 2023
Q2 2023 20.1 -12.3 -37.9% Jun 30, 2023
Q1 2023 22.5 -9.18 -29% Mar 31, 2023
Q4 2022 26.4 +15.8 +150% Dec 31, 2022
Q3 2022 31.5 +28.7 +1050% Sep 30, 2022
Q2 2022 32.4 +29.8 +1118% Jun 30, 2022
Q1 2022 31.6 +28.5 +907% Mar 31, 2022
Q4 2021 10.6 +6.56 +165% Dec 31, 2021
Q3 2021 2.74 -3.78 -58% Sep 30, 2021
Q2 2021 2.66 -7.83 -74.6% Jun 30, 2021
Q1 2021 3.14 -32.4 -91.1% Mar 31, 2021
Q4 2020 3.98 -55.1 -93.3% Dec 31, 2020
Q3 2020 6.52 -47.5 -87.9% Sep 30, 2020
Q2 2020 10.5 -36.3 -77.6% Jun 30, 2020
Q1 2020 35.5 -1.31 -3.56% Mar 31, 2020
Q4 2019 59.1 +37.9 +178% Dec 31, 2019
Q3 2019 54 +32.4 +150% Sep 30, 2019
Q2 2019 46.8 +25.7 +122% Jun 30, 2019
Q1 2019 36.8 +13.5 +57.7% Mar 31, 2019
Q4 2018 21.3 -1.84 -7.97% Dec 31, 2018
Q3 2018 21.6 -9.45 -30.5% Sep 30, 2018
Q2 2018 21.1 -37 -63.7% Jun 30, 2018
Q1 2018 23.3 -69.2 -74.8% Mar 31, 2018
Q4 2017 23.1 -186 -89% Dec 31, 2017
Q3 2017 31 -245 -88.8% Sep 30, 2017
Q2 2017 58 -462 -88.8% Jun 30, 2017
Q1 2017 92.5 -679 -88% Mar 31, 2017
Q4 2016 209 -705 -77.1% Dec 31, 2016
Q3 2016 276 -1.33K -82.8% Sep 30, 2016
Q2 2016 520 -1.55K -74.8% Jun 30, 2016
Q1 2016 772 -1.21K -61.1% Mar 31, 2016
Q4 2015 914 -1.21K -56.9% Dec 31, 2015
Q3 2015 1.61K -631 -28.2% Sep 30, 2015
Q2 2015 2.07K -106 -4.86% Jun 30, 2015
Q1 2015 1.99K +17.6 +0.89% Mar 31, 2015
Q4 2014 2.12K +239 +12.7% Dec 31, 2014
Q3 2014 2.24K +1.18K +111% Sep 30, 2014
Q2 2014 2.17K +1.78K +462% Jun 30, 2014
Q1 2014 1.97K +1.71K +656% Mar 31, 2014
Q4 2013 1.88K +1.64K +690% Dec 31, 2013
Q3 2013 1.06K +678 +177% Sep 30, 2013
Q2 2013 386 -427 -52.5% Jun 30, 2013
Q1 2013 261 -1.37K -84% Mar 31, 2013
Q4 2012 238 Dec 31, 2012
Q3 2012 383 Sep 30, 2012
Q2 2012 813 Jun 30, 2012
Q1 2012 1.63K Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.